Spijkers-Hagelstein JA - Search Results

1

Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.

Spijkers-Hagelstein JA, Pinhanços SS, Schneider P, Pieters R, Stam RW. Spijkers-Hagelstein JA, et al. Leukemia. 2014 Apr;28(4):761-9. doi: 10.1038/leu.2013.245. Epub 2013 Aug 20. Leukemia. 2014. PMID: 23958920

2

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.

Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW. Driessen EM, et al. Among authors: spijkers hagelstein ja. Haematologica. 2013 Jun;98(6):937-44. doi: 10.3324/haematol.2012.067983. Epub 2013 Feb 12. Haematologica. 2013. PMID: 23403319 Free PMC article.

3

Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.

Spijkers-Hagelstein JA, Schneider P, Pinhanços SM, Garrido Castro P, Pieters R, Stam RW. Spijkers-Hagelstein JA, et al. Eur J Cancer. 2014 Jun;50(9):1665-74. doi: 10.1016/j.ejca.2014.03.011. Epub 2014 Apr 3. Eur J Cancer. 2014. PMID: 24703900

4

Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.

Spijkers-Hagelstein JA, Schneider P, Hulleman E, de Boer J, Williams O, Pieters R, Stam RW. Spijkers-Hagelstein JA, et al. Leukemia. 2012 Jun;26(6):1255-65. doi: 10.1038/leu.2011.388. Epub 2012 Jan 27. Leukemia. 2012. PMID: 22282267

5

Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.

Spijkers-Hagelstein JA, Mimoso Pinhanços S, Schneider P, Pieters R, Stam RW. Spijkers-Hagelstein JA, et al. Leukemia. 2013 Apr;27(5):1063-71. doi: 10.1038/leu.2012.372. Epub 2012 Dec 28. Leukemia. 2013. PMID: 23334362

6

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.

Canté-Barrett K, Spijkers-Hagelstein JA, Buijs-Gladdines JG, Uitdehaag JC, Smits WK, van der Zwet J, Buijsman RC, Zaman GJ, Pieters R, Meijerink JP. Canté-Barrett K, et al. Among authors: spijkers hagelstein ja. Leukemia. 2016 Sep;30(9):1832-43. doi: 10.1038/leu.2016.83. Epub 2016 Apr 22. Leukemia. 2016. PMID: 27174491 Free PMC article.

7

Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.

Uitdehaag JC, de Roos JA, van Doornmalen AM, Prinsen MB, Spijkers-Hagelstein JA, de Vetter JR, de Man J, Buijsman RC, Zaman GJ. Uitdehaag JC, et al. Among authors: spijkers hagelstein ja. PLoS One. 2015 May 27;10(5):e0125021. doi: 10.1371/journal.pone.0125021. eCollection 2015. PLoS One. 2015. PMID: 26018524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters